Sun Pharma Q1 Results: Taro Troubles In U.S. Cause Over Rs 1,600-Crore Loss
Signage is displayed at the Sun Pharmaceutical Industries Ltd. headquarters in Mumbai, India. (Photographer: Kanishka Sonthalia/Bloomberg)

Sun Pharma Q1 Results: Taro Troubles In U.S. Cause Over Rs 1,600-Crore Loss

Sun Pharmaceutical Industries Ltd. reported a net loss for the quarter ended June as it provided for the resolution of multi-year investigations against its U.S. subsidiary— Taro Pharmaceutical Ind...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.